BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34263111)

  • 1. Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations.
    Salas E; Farm M; Pich S; Onelöv L; Guillen K; Ortega I; Antovic JP; Soria JM
    TH Open; 2021 Jul; 5(3):e303-e311. PubMed ID: 34263111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilocus genetic risk scores for venous thromboembolism risk assessment.
    Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
    J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.
    Rubio-Terrés C; Soria JM; Morange PE; Souto JC; Suchon P; Mateo J; Saut N; Rubio-Rodríguez D; Sala J; Gracia A; Pich S; Salas E
    Appl Health Econ Health Policy; 2015 Apr; 13(2):233-42. PubMed ID: 25652150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
    Martín AJ; Ziyatdinov A; Rubio VC; Olmos VP; Huerta BM; Rodríguez JC; Fernández MS; de Castro EM; Caro RL; Fernández JM
    Thromb Res; 2016 Apr; 140 Suppl 1():S177-8. PubMed ID: 27161691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.
    Bruzelius M; Bottai M; Sabater-Lleal M; Strawbridge RJ; Bergendal A; Silveira A; Sundström A; Kieler H; Hamsten A; Odeberg J
    J Thromb Haemost; 2015 Feb; 13(2):219-27. PubMed ID: 25472531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.
    Bastos-Oreiro M; Ortiz J; Pradillo V; Salas E; Marínez-Laperche C; Muñoz A; Buño I; Diéz-Martin JL; Soria JM; Pascual Izquierdo C
    Cancer Med; 2021 Nov; 10(21):7585-7592. PubMed ID: 34598309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk factors for venous thromboembolism.
    Zöller B; Svensson PJ; Dahlbäck B; Lind-Hallden C; Hallden C; Elf J
    Expert Rev Hematol; 2020 Sep; 13(9):971-981. PubMed ID: 32731838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.
    Lobastov K; Dementieva G; Soshitova N; Bargandzhiya A; Barinov V; Laberko L; Rodoman G
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):31-41. PubMed ID: 31495765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS; Miletich JP; Goldhaber SZ; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2001 Jan; 37(1):215-8. PubMed ID: 11153741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
    Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.